Parkash Gill
Corporate Officer/Principal bei University of Southern California
Profil
Parkash Gill is the founder of VasGene Therapeutics, Inc. which was founded in 1999.
He held the title of Director at VasGene Therapeutics, Inc. Dr. Gill's current job is Medicine Professor at the University of Southern California.
Dr. Gill's former job was as Director at NuRx Pharmaceuticals, Inc. from 2007 to 2009.
Aktive Positionen von Parkash Gill
| Unternehmen | Position | Beginn |
|---|---|---|
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services University of Southern California is a private research university that mainly offers undergraduate, graduate & other higher education. The university was founded in 1880 and is headquartered in Los Angeles, CA. | Corporate Officer/Principal | 15.08.2011 |
Ehemalige bekannte Positionen von Parkash Gill
| Unternehmen | Position | Ende |
|---|---|---|
| NURX PHARMACEUTICALS INC | Direktor/Vorstandsmitglied | 13.06.2009 |
VasGene Therapeutics, Inc.
 VasGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services VasGene Therapeutics, Inc. developed therapeutics based on vascular biology. Its products included target signal transduction pathways common to cancer cells and endothelial cells, resulting in anti-cancer agents with multiple modes of action and inhibition of tumor cell growth, anti-angiogenesis and prevention of tumor cell metastasis. The company was founded by Raymond A. Mirra Jr. and Parkash Gill in 1999 and was headquartered in Oak Park, CA. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
NuRx Pharmaceuticals, Inc.
 NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NuRx Pharmaceuticals, Inc. manufactures pharmaceutical products. It engages in treatment of cancer, chemotherapy associated neutropenia, bone marrow function, bone metabolism and lipid metabolism. The company was founded on August 14, 2001 and is headquartered in Irvine, CA. | Health Technology |
VasGene Therapeutics, Inc.
VasGene Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services VasGene Therapeutics, Inc. developed therapeutics based on vascular biology. Its products included target signal transduction pathways common to cancer cells and endothelial cells, resulting in anti-cancer agents with multiple modes of action and inhibition of tumor cell growth, anti-angiogenesis and prevention of tumor cell metastasis. The company was founded by Raymond A. Mirra Jr. and Parkash Gill in 1999 and was headquartered in Oak Park, CA. | Commercial Services |
